bioprinting research News
-
3D Bioprinting Solutions and URSC Cooperation Agreement - The Development of a Bioprinter for Space Applications
3D Bioprinting Solutions, a resident company of Skolkovo Innovation Center has entered into a cooperation agreement with URSC (Unified Rocket and Space Corporation, a member of ROSCOSMOS State Corporation), aiming to create a unique bioprinter capable of magnetic biofabrication of tissue and organ constructs in zero-gravity at the International Space Station (ISS). It was signed by the URSC ...
-
BICO acquires Allegro 3D, adding new light-based 3D bioprinting technology – complementing the existing offering of application tailored products
Adding Allegro 3D to the portfolio enables BICO Bioprinting to strengthen its position as the global leader in providing 3D bioprinters. BICO has a robust portfolio of bioprinters, utilizing extrusion based, 2PP and DLP technologies. BICO has acquired all the shares in San Diego-based Allegro 3D Inc. (“Allegro 3D”) for an up-front enterprise value of USD 6 million. Additionally, ...
-
CELLINK and the University of California, San Diego Partner to Open a 3D Bioprinting Centre of Excellence
CELLINK, a leading global provider of bioprinting technologies, and the University of California, San Diego (UCSD), a world-renowned research institution, are pleased to announce their partnership to establish a 3D bioprinting Centre of Excellence. This partnership aims to facilitate the utilization of advanced bioprinting technologies and promote cutting-edge research in the fields of drug ...
By CELLINK
-
VIVAX BIO on a mission for COVID-19 drug discovery
Following its aspiring mission “Creating future opportunities” the biotechnological research laboratory “3D Bioprinting Solutions” and VIVAX BIO take an active part in pharmacological studies of various antiviral drugs. During the most difficult challenge in recent healthcare history cell biologists from the laboratory's research team began working with leading virologists ...
-
Poietis and Assistance Publique – Hôpitaux de Marseille (AP-HM) annouce the first installation of a 3D bioprinting platform for manufacturing implantable biological tissues in hospitals
The installation of the NGB (Next-Generation Bioprinting) robotic bioprinting platform developed by Poietis in the Advanced Therapy Medicinal Product (ATMP) manufacturing area of the Hôpital de la Conception represents a world premiere and opens up very promising perspectives in regenerative medicine. The objective is now to start the first clinical trial of a 3D printed ...
By Poietis
-
VIVAX BIO, 3D Bioprinting Solutions, and partners complete the first cultured meat biofabrication experiment on board the ISS.
3D Bioprinting Solutions biotechnology laboratory, Meal Source Technologies, as well as Aleph Farms and Finless Foods, are proud to announce successful result of the joint project which involved magnetic biofabrication of bovine, mummichog and rabbit myoblast/fibroblast constructs in order to lay the groundwork for renewable protein sources for long term manned missions. Additionally, results of ...
-
Poietis signs a clinical research collaboration contract with the Assistance Publique – Hôpitaux de Marseille (AP-HM) to prepare the first clinical trial of a bioprinted skin.
Poietis, leading bioprinting company, and the « Assistance Publique – Hôpitaux de Marseille » (AP-HM) announced today that they have entered into a partnership through the signature the 20th of January of a clinical research collaboration contract on a bioprinted tissue engineering product. The objective of this agreement is to carry out within two years a Phase I clinical ...
By Poietis
-
Carcinotech and CELLINK Enter a Partnership to Develop and Commercialize Protocols for Cancer Models to Provide Improved Speed and Accuracy in the Drug Development Processes
Carcinotech and CELLINK are pleased to announce a collaborative partnership to develop and commercialize protocols for the biofabrication of 3D bioprinted tumor models based on cancer cell lines that improve accuracy and rapidly speed up drug development processes, driving down development costs and enabling an improved output. The protocols will be available for use on the BIO CELLX system ...
By CELLINK
-
Poietis announces formation of Scientific Advisory Board and appoints two first prominent Regenerative Medicine experts
Poietis, 4D Bioprinting company, announces formation of Scientific Advisory Board (SAB) and appointment of two first prominent Scientists in Regenerative Medicine. The SAB will serve as a key strategic resource to Poietis as the company expands capabilities of Next- Generation Bioprinting (NGB) platform to therapeutic applications and develops first implantable tissues such as a ...
By Poietis
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you